Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL
作者： Kevin Marley , Shay Bracha , Bernard Seguin
DOI: 10.1016/J.YEXCR.2015.08.001
关键词:
摘要: … Osteosarcoma (OS) is an aggressive and often fatal cancer that … of RANK and RANKL in osteosarcoma tumors and cell lines … considering OPG as a therapeutic agent for osteosarcoma. …
core.ac.uk
cyberleninka.org
oregonstate.edu
sci-hub.se 参考文章(32)
Michiyo Kobayashi-Sakamoto, Emiko Isogai, Ingunn Holen, Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells European Journal of Haematology. ,vol. 85, pp. no- no ,(2010) , 10.1111/J.1600-0609.2010.01446.X
N. E. Kushlinskii, Yu. S. Timofeev, Yu. N. Solov’ev, E. S. Gerstein, N. V. Lyubimova, I. V. Bulycheva, Components of the RANK/RANKL/OPG System, IL-6, IL-8, IL-16, MMP-2, and Calcitonin in the Sera of Patients with Bone Tumors Bulletin of Experimental Biology and Medicine. ,vol. 157, pp. 520- 523 ,(2014) , 10.1007/S10517-014-2605-Y
Anja Luetke, Paul A. Meyers, Ian Lewis, Heribert Juergens, Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treatment Reviews. ,vol. 40, pp. 523- 532 ,(2014) , 10.1016/J.CTRV.2013.11.006
K Mori, B Le Goff, M Berreur, A Riet, A Moreau, F Blanchard, C Chevalier, I Guisle-Marsollier, J Léger, J Guicheux, M Masson, F Gouin, F Rédini, D Heymann, Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. The Journal of Pathology. ,vol. 211, pp. 555- 562 ,(2007) , 10.1002/PATH.2140
William C. Dougall, Michelle Chaisson, The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer and Metastasis Reviews. ,vol. 25, pp. 541- 549 ,(2007) , 10.1007/S10555-006-9021-3
Kanji Mori, Martine Berreur, Fréderic Blanchard, Catherine Chevalier, Isabelle Guisle-Marsollier, Martial Masson, Françoise Rédini, Dominique Heymann, Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells. Oncology Reports. ,vol. 18, pp. 1365- 1371 ,(2007) , 10.3892/OR.18.6.1365
Aaron L. Sabbota, Hyeong-Reh Choi Kim, Xiaoning Zhe, Rafael Fridman, R. Daniel Bonfil, Michael L. Cher, Shedding of RANKL by Tumor-Associated MT1-MMP Activates Src-dependent Prostate Cancer Cell Migration Cancer Research. ,vol. 70, pp. 5558- 5566 ,(2010) , 10.1158/0008-5472.CAN-09-4416
B. Séguin, T. Zwerdling, J. L. McCallan, H. E. V. DeCock, L. L. Dewe, D. K. Naydan, A. E. Young, D. L. Bannasch, O. Foreman, M. S. Kent, Development of a new canine osteosarcoma cell line Veterinary and Comparative Oncology. ,vol. 4, pp. 232- 240 ,(2006) , 10.1111/J.1476-5829.2006.00112.X
Toru Ogasawara, Mika Katagiri, Aiichiro Yamamoto, Kazuto Hoshi, Tsuyoshi Takato, Kozo Nakamura, Sakae Tanaka, Hiroto Okayama, Hiroshi Kawaguchi, Osteoclast Differentiation by RANKL Requires NF‐κB‐Mediated Downregulation of Cyclin‐Dependent Kinase 6 (Cdk6) Journal of Bone and Mineral Research. ,vol. 19, pp. 1128- 1136 ,(2004) , 10.1359/JBMR.2004.19.7.1128
Neil D. Perkins, The diverse and complex roles of NF-κB subunits in cancer Nature Reviews Cancer. ,vol. 12, pp. 121- 132 ,(2012) , 10.1038/NRC3204